The Natsimbio holding (part of the Rostec Group) has developed and started production of the domestic drug BioGam. It is intended for the therapy of patients with primary and secondary immunodeficiencies. This was reported by the press service of the state corporation.
BioGam is included in the list of vital medicines, its production will replace imported analogues on the Russian market. Today, it is the only Russian intravenous human immunoglobulin with a concentration of 10%.
Drugs in this dosage are crucial for the quality of life of patients with immunodeficiencies. The fact is that a high concentration allows you to achieve optimal results in the treatment of immunodeficiencies with smaller volumes of the injected drug and in a shorter time.
The first batch of 5 thousand packages will arrive this year. Production volumes are planned to increase in 2025.
Earlier www1.ru reported that Active Component will build a pharmaceutical substance plant in St. Petersburg by 2025.
Read materials on the topic:
New antibiotics will appear in Russia
Russian scientists have created a wine that protects the kidneys from X-ray radiation
Now on home
Start of deliveries scheduled for 2027
Over 51,000 new motorcycles were sold in Russia in 2025
The car will take at least a year to assemble
The application's audience has reached 20 million users
The model will be included in the list of cars for taxis, price - from 2.25 million rubles
All parking lots of the "Administrator of the Moscow Parking Space" are connected to the service
The cars will be supplied to the Moscow Transport Service Directorate
Deliveries to India may begin in 2028
The technology provides automated search for all types of defects in power units
The plane flew 500 km, accelerating to 425 km/h
The plant stated that the information about the termination of purchases for models 6 and 8 is not true
Scientists are using the "Ekran-M" installation